Investing in people
inventing the future
Lux Capital invests in emerging science and technology ventures at the outermost edges of what is possible.
We partner with iconoclastic inventors challenging the status quo and the laws of nature to bring their futuristic ideas to life.Play Video Discover LUX
Want to know what the future will look like? Spend some time with our companies. You might meet a genetic engineer programming matter at the molecular level; a biologist and electrical engineer designing a new surgical robot; an astrophysicist launching rockets into space; or a materials scientist making circuits using a technique lifted from once-classified government programs.
Aeva has created a new sensing paradigm for autonomous machines. The company listed publicly [NYSE: AEVA] in 2021.
Auris Health is an ambitious robotics company based in Silicon Valley. Auris was acquired for up to $6.1B by Johnson & Johnson in 2019.
CTRL-labs is changing the way we interact with computers. CTRL-labs was acquired by Facebook in 2019.
Desktop Metal enables high-speed, high-performance, 3D metal printing at production scale. The company listed publicly [NYSE: DM] in 2020.
Latch is building the first universal smart-access platform. The company’s mission is to enable flexible, seamless and secure digital access to physical spaces.
Matterport is the world’s most powerful all-in-one 3D data platform lets you turn a space into an accurate and immersive digital twin.
Recursion Pharma is combining high-throughput experimental biology, bioinformatics, and machine learning to rapidly identify new indications for many known drugs and shelved assets. The company completed its IPO [NASDAQ: RXRX] in 2021.
Saildrone collects valuable ocean data using a fleet of unmanned, autonomous sailing drones.
Our team is willing to take a chance on something other investors do not see.
We are neuroscientists, chemists, data scientists, computational biologists, economists, electrical engineers, machine-learning hackers and philosophers. We get fired up when audacious experimentation leads to heresy and reinvention.
News & Insights
Pawp Raises $13M Series A to Make Quality Pet Care Affordable and AccessibleMac Atiyeh
May 7, 2021
Dyno grabs $100M to expand tech, build team, ink more gene therapy partnerships
May 7, 2021
Science 37 to Become Publicly Listed
May 6, 2021
Roger Perlmutter, former Merck R&D head, becomes CEO of super-microscopy startup
May 3, 2021
Investing in Alife Health: AI Takes on the Fertility Crisis
May 3, 2021
Lux Capital Leads Seed Financing for Fertility-Tech Startup Alife